Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Johnson & Johnson (JNJ)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Johnson & Johnson.
Table 2 shows the detailed insider transactions.
This company's CIK number is 200406.
Total stock buying since 2015: $2,435,223.
Total stock sales since 2015: $413,300,517.
Total stock option exercises since 2015: $259,720,439.
Table 3. Detailed insider trading at Johnson & Johnson (JNJ)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-08-29 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 11,521 | 115.67 | 1,332,634 |
| 2025-08-22 | Duato Joaquin (CEO and Chairman of the Board) | Sale | 125,824 | 179.21 | 22,548,667 |
| 2025-08-22 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 125,824 | 101.87 | 12,817,690 |
| 2025-08-15 | Wolk Joseph J (Exec VP, CFO) | Sale | 16,820 | 176.91 | 2,975,575 |
| 2025-08-15 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 16,820 | 101.87 | 1,713,453 |
| 2025-07-17 | Reed John C (EVP, Innovative Medicine, R&D) | Sale | 19,137 | 163.55 | 3,129,837 |
| 2025-05-01 | Reed John C (EVP, Innovative Medicine, R&D) | Option Ex | 25,255 | .00 | 0 |
| 2025-02-25 | Decker Robert J (VP Corporate Controller) | Sale | 6,999 | 165.88 | 1,160,994 |
| 2025-02-25 | Decker Robert J (VP Corporate Controller) | Option Ex | 6,999 | 101.87 | 712,988 |
| 2025-02-18 | Schmid Timothy (EVP, WW Chair, MedTech) | Sale | 806 | 156.15 | 125,856 |
| 2025-02-15 | Mulholland Kristen (EVP, Chief HR Officer) | Option Ex | 838 | .00 | 0 |
| 2025-02-15 | Schmid Timothy (EVP, WW Chair, MedTech) | Option Ex | 2,058 | .00 | 0 |
| 2025-02-15 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 1,922 | .00 | 0 |
| 2025-02-15 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 984 | .00 | 0 |
| 2025-02-15 | Swanson James D. (EVP, CIO) | Option Ex | 984 | .00 | 0 |
| 2025-02-15 | Decker Robert J (VP Corporate Controller) | Option Ex | 678 | .00 | 0 |
| 2025-02-15 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 1,214 | .00 | 0 |
| 2025-02-15 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 3,188 | .00 | 0 |
| 2025-02-15 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 3,942 | .00 | 0 |
| 2025-02-15 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 7,364 | .00 | 0 |
| 2025-02-15 | Reed John C (EVP, Innovative Medicine, R&D) | Option Ex | 2,700 | .00 | 0 |
| 2025-02-14 | Mulholland Kristen (EVP, Chief HR Officer) | Option Ex | 5,216 | .00 | 0 |
| 2025-02-14 | Schmid Timothy (EVP, WW Chair, MedTech) | Option Ex | 9,142 | .00 | 0 |
| 2025-02-14 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 4,406 | .00 | 0 |
| 2025-02-14 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 9,480 | .00 | 0 |
| 2025-02-14 | Swanson James D. (EVP, CIO) | Option Ex | 10,158 | .00 | 0 |
| 2025-02-14 | Decker Robert J (VP Corporate Controller) | Option Ex | 4,402 | .00 | 0 |
| 2025-02-14 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 14,734 | .00 | 0 |
| 2025-02-14 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 39,036 | .00 | 0 |
| 2025-02-14 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 38,660 | .00 | 0 |
| 2025-02-14 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 48,670 | .00 | 0 |
| 2025-02-13 | Mulholland Kristen (EVP, Chief HR Officer) | Option Ex | 822 | .00 | 0 |
| 2025-02-13 | Schmid Timothy (EVP, WW Chair, MedTech) | Option Ex | 998 | .00 | 0 |
| 2025-02-13 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 1,302 | .00 | 0 |
| 2025-02-13 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 816 | .00 | 0 |
| 2025-02-13 | Swanson James D. (EVP, CIO) | Option Ex | 894 | .00 | 0 |
| 2025-02-13 | Decker Robert J (VP Corporate Controller) | Option Ex | 624 | .00 | 0 |
| 2025-02-13 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 1,302 | .00 | 0 |
| 2025-02-13 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 2,604 | .00 | 0 |
| 2025-02-13 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 3,558 | .00 | 0 |
| 2025-02-13 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 6,940 | .00 | 0 |
| 2025-02-07 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 32,762 | 100.06 | 3,278,165 |
| 2025-02-07 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 58,504 | 100.06 | 5,853,910 |
| 2025-02-07 | Wolk Joseph J (Exec VP, CFO) | Sale | 13,015 | 153.89 | 2,002,878 |
| 2025-02-07 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 13,015 | 100.06 | 1,302,280 |
| 2025-02-07 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 126,369 | 100.06 | 12,644,482 |
| 2024-12-12 | Weinberger Mark A (Director) | Buy | 1,000 | 147.22 | 147,220 |
| 2024-08-30 | Decker Robert J (VP Corporate Controller) | Sale | 5,635 | 165.06 | 930,113 |
| 2024-08-30 | Decker Robert J (VP Corporate Controller) | Option Ex | 5,635 | 100.06 | 563,838 |
| 2024-07-08 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 9,809 | .00 | 0 |
| 2024-05-01 | Reed John C (EVP, Innovative Medicine, R&D) | Option Ex | 22,255 | .00 | 0 |
| 2024-03-13 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Sale | 8,891 | 162.16 | 1,441,764 |
| 2024-02-13 | Schmid Timothy (EVP, WW Chair, MedTech) | Option Ex | 499 | .00 | 0 |
| 2024-02-13 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 651 | .00 | 0 |
| 2024-02-13 | Hait William (See Remarks) | Option Ex | 834 | .00 | 0 |
| 2024-02-13 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 408 | .00 | 0 |
| 2024-02-13 | Swanson James D. (EVP, CIO) | Option Ex | 447 | .00 | 0 |
| 2024-02-13 | Decker Robert J (VP Corporate Controller) | Option Ex | 313 | .00 | 0 |
| 2024-02-13 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 651 | .00 | 0 |
| 2024-02-13 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 1,302 | .00 | 0 |
| 2024-02-13 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 1,780 | .00 | 0 |
| 2024-02-13 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 925 | .00 | 0 |
| 2024-02-12 | Schmid Timothy (EVP, WW Chair, MedTech) | Option Ex | 5,736 | .00 | 0 |
| 2024-02-12 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 2,859 | .00 | 0 |
| 2024-02-12 | Hait William (See Remarks) | Option Ex | 8,932 | .00 | 0 |
| 2024-02-12 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 4,701 | .00 | 0 |
| 2024-02-12 | Swanson James D. (EVP, CIO) | Option Ex | 5,456 | .00 | 0 |
| 2024-02-12 | Decker Robert J (VP Corporate Controller) | Option Ex | 1,912 | .00 | 0 |
| 2024-02-12 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 13,813 | .00 | 0 |
| 2024-02-12 | Taubert Jennifer L (EVP, WWC. Innovative Medicine) | Option Ex | 26,202 | .00 | 0 |
| 2024-02-12 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 25,835 | .00 | 0 |
| 2024-02-12 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 36,618 | .00 | 0 |
| 2024-02-12 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 14,960 | .00 | 0 |
| 2024-02-09 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 35,638 | 90.44 | 3,223,100 |
| 2024-02-09 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Sale | 59,397 | 156.27 | 9,281,969 |
| 2024-02-09 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 59,397 | 90.44 | 5,371,864 |
| 2024-02-09 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 130,969 | 90.44 | 11,844,836 |
| 2024-02-08 | Forminard Elizabeth (Executive VP, General Counsel) | Option Ex | 979 | .00 | 0 |
| 2024-02-08 | Swanson James D. (See Remarks) | Option Ex | 1,868 | .00 | 0 |
| 2024-02-08 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 1,971 | .00 | 0 |
| 2024-02-08 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 3,739 | .00 | 0 |
| 2024-02-08 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 3,686 | .00 | 0 |
| 2024-02-08 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 5,225 | .00 | 0 |
| 2023-07-26 | Hait William (See Remarks) | Sale | 14,698 | 172.00 | 2,528,056 |
| 2023-07-26 | Hait William (See Remarks) | Option Ex | 14,698 | 90.44 | 1,329,287 |
| 2023-07-25 | Fasolo Peter (Exec VP, Chief HR Officer) | Sale | 20,000 | 170.32 | 3,406,500 |
| 2023-06-12 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Sale | 12,465 | 160.00 | 1,994,400 |
| 2023-03-06 | Swanson James D. (See Remarks) | Sale | 1,061 | 154.66 | 164,094 |
| 2023-02-10 | Hait William (See Remarks) | Option Ex | 3,856 | .00 | 0 |
| 2023-02-10 | Broadhurst Vanessa (EVP, Global Corp Affairs) | Option Ex | 1,592 | .00 | 0 |
| 2023-02-10 | Swanson James D. (See Remarks) | Option Ex | 1,291 | .00 | 0 |
| 2023-02-10 | Decker Robert J (VP Corporate Controller) | Option Ex | 581 | .00 | 0 |
| 2023-02-10 | Mongon Thibaut (Exec VP, WW Chair, Cons Health) | Option Ex | 2,285 | .00 | 0 |
| 2023-02-10 | Wengel Kathryn E (EVP, Chief TO and Risk Officer) | Option Ex | 1,807 | .00 | 0 |
| 2023-02-10 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 3,570 | .00 | 0 |
| 2023-02-10 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 3,449 | .00 | 0 |
| 2023-02-10 | Duato Joaquin (CEO and Chairman of the Board) | Option Ex | 5,220 | .00 | 0 |
| 2023-02-10 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 2,078 | .00 | 0 |
| 2022-11-22 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Sale | 153,846 | 176.78 | 27,196,742 |
| 2022-11-22 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 153,846 | 72.54 | 11,159,988 |
| 2022-11-18 | Decker Robert J (Controller, CAO) | Sale | 16,928 | 175.00 | 2,962,400 |
| 2022-11-18 | Decker Robert J (Controller, CAO) | Option Ex | 16,928 | 90.44 | 1,530,968 |
| 2022-11-09 | Wengel Kathryn E (EVP, Chief GSC Officer) | Sale | 16,410 | 173.42 | 2,845,772 |
| 2022-11-09 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 16,410 | 72.54 | 1,190,381 |
| 2022-11-02 | Swanson James D. (EVP, Chief Information Officer) | Option Ex | 9,912 | .00 | 0 |
| 2022-10-24 | Fasolo Peter (Exec VP, Chief HR Officer) | Sale | 78,458 | 171.09 | 13,435,385 |
| 2022-10-24 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 78,458 | 115.67 | 9,075,236 |
| 2022-10-19 | Fasolo Peter (Exec VP, Chief HR Officer) | Sale | 210,378 | 164.50 | 34,607,805 |
| 2022-10-19 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 210,378 | 101.87 | 21,431,205 |
| 2022-06-10 | Wengel Kathryn E (EVP, Chief GSC Officer) | Sale | 40,000 | 173.00 | 6,920,040 |
| 2022-06-10 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 40,000 | 72.54 | 2,901,600 |
| 2022-05-26 | Decker Robert J (Controller, CAO) | Sale | 8,462 | 180.00 | 1,523,160 |
| 2022-05-26 | Decker Robert J (Controller, CAO) | Option Ex | 8,462 | 72.54 | 613,833 |
| 2022-03-17 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Sale | 34,555 | 176.26 | 6,090,707 |
| 2022-03-17 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 30,785 | 100.97 | 3,108,207 |
| 2022-03-15 | Decker Robert J (Controller, CAO) | Sale | 5,000 | 175.51 | 877,530 |
| 2022-03-15 | Decker Robert J (Controller, CAO) | Option Ex | 5,000 | 72.54 | 362,700 |
| 2022-02-15 | Hait William (See Remarks) | Option Ex | 8,128 | .00 | 0 |
| 2022-02-15 | Broadhurst Vanessa (EVP, Global Corp Aff.) | Option Ex | 2,557 | .00 | 0 |
| 2022-02-15 | Decker Robert J (Controller, CAO) | Option Ex | 903 | .00 | 0 |
| 2022-02-15 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 3,922 | .00 | 0 |
| 2022-02-15 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 10,386 | .00 | 0 |
| 2022-02-15 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 18,064 | .00 | 0 |
| 2022-02-15 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 15,806 | .00 | 0 |
| 2022-02-15 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 17,793 | .00 | 0 |
| 2022-02-15 | Duato Joaquin (CEO) | Option Ex | 29,714 | .00 | 0 |
| 2022-02-15 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 13,186 | .00 | 0 |
| 2022-02-15 | Gorsky Alex (Director) | Option Ex | 60,965 | .00 | 0 |
| 2022-02-15 | Mammen Mathai (EVP, Pharm, R&D) | Option Ex | 7,740 | .00 | 0 |
| 2022-02-14 | Hait William (See Remarks) | Option Ex | 7,790 | .00 | 0 |
| 2022-02-14 | Broadhurst Vanessa (EVP, Global Corp Aff.) | Option Ex | 2,451 | .00 | 0 |
| 2022-02-14 | Decker Robert J (Controller, CAO) | Option Ex | 866 | .00 | 0 |
| 2022-02-14 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 3,759 | .00 | 0 |
| 2022-02-14 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 1,896 | .00 | 0 |
| 2022-02-14 | Taubert Jennifer L (EVP, WW Chair, Pharmaceuticals) | Option Ex | 3,297 | .00 | 0 |
| 2022-02-14 | Mcevoy Ashley (EVP, WW Chair, Medical Devices) | Option Ex | 2,885 | .00 | 0 |
| 2022-02-14 | Wolk Joseph J (Exec VP, CFO) | Option Ex | 3,248 | .00 | 0 |
| 2022-02-14 | Duato Joaquin (CEO) | Option Ex | 5,424 | .00 | 0 |
| 2022-02-14 | Ullmann Michael H (Exec VP, General Counsel) | Option Ex | 2,407 | .00 | 0 |
| 2022-02-14 | Fasolo Peter (Exec VP, Chief HR Officer) | Option Ex | 13,190 | .00 | 0 |
| 2022-02-14 | Gorsky Alex (Director) | Option Ex | 11,129 | .00 | 0 |
| 2022-02-14 | Mammen Mathai (EVP, Pharm, R&D) | Option Ex | 7,418 | .00 | 0 |
| 2022-01-14 | Duato Joaquin (CEO) | Option Ex | 84,423 | 65.37 | 5,518,731 |
| 2022-01-14 | Gorsky Alex (Director) | Option Ex | 231,951 | 65.37 | 15,162,636 |
| 2021-12-07 | Decker Robert J (Controller, CAO) | Sale | 5,000 | 163.21 | 816,050 |
| 2021-12-07 | Decker Robert J (Controller, CAO) | Option Ex | 5,000 | 72.54 | 362,700 |
| 2021-02-12 | Decker Robert J (Controller, CAO) | Option Ex | 1,310 | .00 | 0 |
| 2021-02-12 | Mongon Thibaut (Exec VP, WW Chair, Consumer) | Option Ex | 7,145 | .00 | 0 |
| 2021-02-12 | Wengel Kathryn E (EVP, Chief GSC Officer) | Option Ex | 10,362 | .00 | 0 |
| 2021-02-12 | Sneed Michael E (EVP, Global Corp Aff & CCO) | Option Ex | 9,211 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of JNJ listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Johnson & Johnson (symbol JNJ,
CIK number 200406) see
the Securities and Exchange Commission (SEC) website.